Amiodarone	amiodarone	CHEMICALS	O	OTHERS	I
pulmonary	pulmonary	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Amiodarone	amiodarone	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
an	an	O	O	O	O
effective	effective	O	O	O	O
antiarrhythmic	antiarrhythmic	O	O	O	O
agent	agent	O	O	O	O
whose	whose	O	O	O	O
utility	utility	O	O	O	O
is	is	O	O	O	O
limited	limited	O	O	O	O
by	by	O	O	O	O
many	many	O	O	O	O
side-effects	side-effects	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
most	most	O	O	O	O
problematic	problematic	O	O	O	O
being	being	O	O	O	O
pneumonitis	pneumonitis	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
pulmonary	pulmonary	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
of	of	O	O	O	O
amiodarone	amiodarone	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
thought	thought	O	O	O	O
to	to	O	O	O	O
result	result	O	O	O	O
from	from	O	O	O	O
direct	direct	O	O	O	O
injury	injury	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
intracellular	intracellular	O	O	O	O
accumulation	accumulation	O	O	O	O
of	of	O	O	O	O
phospholipid	phospholipid	O	O	O	O
and	and	O	O	O	O
T	t	O	O	O	O
cell-mediated	cell-mediated	O	O	O	O
hypersensitivity	hypersensitivity	O	DISEASE	OTHERS	I
pneumonitis	pneumonitis	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
clinical	clinical	O	O	O	O
and	and	O	O	O	O
radiographic	radiographic	O	O	O	O
features	features	O	O	O	O
of	of	O	O	O	O
amiodarone-induced	amiodarone-induced	O	O	O	O
pulmonary	pulmonary	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
are	are	O	O	O	O
characteristic	characteristic	O	O	O	O
but	but	O	O	O	O
nonspecific	nonspecific	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
diagnosis	diagnosis	O	O	O	O
depends	depends	O	O	O	O
on	on	O	O	O	O
exclusion	exclusion	O	O	O	O
of	of	O	O	O	O
other	other	O	O	O	O
entities	entities	O	O	O	O
,	,	O	O	O	O
such	such	O	O	O	O
as	as	O	O	O	O
heart	heart	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
,	,	O	O	O	O
infection	infection	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
malignancy	malignancy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

While	while	O	O	O	O
withdrawal	withdrawal	O	O	O	O
of	of	O	O	O	O
amiodarone	amiodarone	CHEMICALS	O	OTHERS	I
leads	leads	O	O	O	O
to	to	O	O	O	O
clinical	clinical	O	O	O	O
improvement	improvement	O	O	O	O
in	in	O	O	O	O
majority	majority	O	O	O	O
of	of	O	O	O	O
cases	cases	O	O	O	O
,	,	O	O	O	O
this	this	O	O	O	O
is	is	O	O	O	O
not	not	O	O	O	O
always	always	O	O	O	O
possible	possible	O	O	O	O
or	or	O	O	O	O
advisable	advisable	O	O	O	O
.	.	O	O	O	O

Dose	dose	O	O	O	O
reduction	reduction	O	O	O	O
or	or	O	O	O	O
concomitant	concomitant	O	O	O	O
steroid	steroid	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
may	may	O	O	O	O
have	have	O	O	O	O
a	a	O	O	O	O
role	role	O	O	O	O
in	in	O	O	O	O
selected	selected	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

